Modest growth seen in epilepsy market.
The epilepsy market's $4.2 billion in global sales in 2012 is expected to increase to $5.4 billion by 2022. In a market crowded with products, pharmaceutical companies have shifted their focus to devising safe adjunctive therapies for refractory patients.
Kunj
K
Gohil
Devin
D
Enhoffer